HROW
Harrow, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arrow.com
- Employees(FY) 217
- ISIN US4158581094
Performance
+62.88%
1W
+36.26%
1M
+57.08%
3M
+94.88%
6M
+49.64%
YTD
-22.44%
1Y
Profile
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic medicines, including IOPIDINE and MOXEZA; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and MAQ-100, a preservative-free triamcinolone acetonide ophthalmic injection drug candidate. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Technical Analysis of HROW 2024-05-10
Overview:
In analyzing the technical indicators for HROW over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-15 07:00
Harrow to Present at Two Investor Conferences in May(Business Wire)
- 2024-05-14 19:00
Harrow to Present at Two Investor Conferences in May(Businesswire)
- 2024-05-13 16:01
Harrow Announces First Quarter 2024 Financial Results(Business Wire)
- 2024-05-13 08:55
- 2024-05-13 07:00
- 2024-05-13 04:25
- 2024-05-13 04:01
Harrow Announces First Quarter 2024 Financial Results(Businesswire)
- 2024-05-12 19:00
- 2024-04-25 07:00
- 2024-04-24 19:00
- 2024-04-01 20:16
- 2024-03-20 21:55
- 2024-03-19 17:45
- 2024-03-19 09:52
- 2024-03-19 06:51
- 2024-03-19 05:45
- 2024-03-13 06:35
Harrow (HROW) Fell on Lowering the Guidance(Insider Monkey)
- 2024-03-12 18:35
Harrow (HROW) Fell on Lowering the Guidance(Insidermonkey)
- 2024-03-05 07:00
- 2024-03-04 18:00
- 2024-03-04 07:28
11 Best Small Cap Pharma Stocks to Invest In(Insidermonkey)
- 2024-02-20 17:47
Heres How Harrow (HROW) Weighed on SRK Capitals Performance(Yahoo Finance)
- 2024-02-15 16:01
- 2024-02-15 03:01
- 2024-01-28 18:00
- 2024-01-10 18:00
- 2024-01-02 18:15
Melt Pharmaceuticals Provides Corporate Update(Yahoo Finance)
- 2024-01-02 18:00
- 2023-12-24 00:08
7 Short-Squeeze Stocks That Are Screaming for Speculation(Yahoo Finance)
- 2023-11-28 18:00
Page 1 of 5
previousnext